About Bastian Arlt
This author has not written his bio yet.
But we are proud to say that Bastian Arlt contributed 59 entries already.
Entries by Bastian Arlt
Patent on oral formulations of a Pyridinone derivate
Abstract This patent describes an oral formulation designed to selectively deliver the drug (a Pyridinone derivate) to the small intestine. The formulation consists of coated granules, pellets, beads, minicapsules, or minitablets containing a specific compound used for treating intestinal fibrosis, particularly fibrostenotic Crohn’s disease. The particles include a core material and an enteric coating polymer, […]
Patent on enteric-coated particles containing lactoferrin
Abstract The present invention generally relates to enteric-coated particles containing lactoferrin. More specifically, the present invention provides an enteric-coated particle comprising (or consisting essentially of): a) a core comprising (or consisting essentially of) an inert core-forming material selected from cellulose polymer, sugar, sugar alcohol, starch and carnauba wax; b) a first coating layer substantially covering […]
Revealing the physical restrictions of caecal influx in broilers through the use of solid and soluble markers
Paulien Vanderghinste, An Bautil, Michael R. Bedford, Gemma González-Ortiz, Chris Lamberigts, Imran Aslam, Maarten Roeffaers, Christophe M. Courtin Abstract A promising strategy to support broiler health and performance in a sustainable way is the enhancement of microbial fibre fermentation in broilers. This fermentation mainly occurs in the caeca, but the actual particle size range that […]
Conclusion of the Blog Series: Innovations in Controlled Drug Release
Over the past few weeks, we have explored the fascinating world of patents related to controlled and modified drug release through our eight-part blog series. This journey has taken us from the extended release of pyridostigmine and atomoxetine to the innovative formulations of gamma-hydroxybutyrate. 🚀💊 Each entry provided valuable insights into the advancements in Cellets […]
Patent on pharmaceutical compositions and methods for treating hyperhidrosis
The patent application US20240350420A1 focuses on pharmaceutical formulations and methods for treating conditions such as hyperhidrosis, which involves excessive sweating. The document details the development of modified-release compositions, specifically utilizing Pilocarpine HCl, a muscarinic agonist. These formulations aim to optimize drug delivery by employing various release mechanisms, including immediate, delayed, or sustained release. The innovations […]
Patent on gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
Patents US20240350437A1 and US20240350438A1 – Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state – Google Patents relates to pharmaceutical compositions and systems designed to provide controlled and consistent drug release for oral administration. The invention addresses challenges associated with delayed or multi-stage drug delivery, particularly for active pharmaceutical ingredients (APIs) with complex absorption profiles […]
What does AI say about CELLETS?
Did you ever wonder, what AI engines say about CELLETS? Artificial Intelligence engines answers by example of ChatGPT, version GPT-4o executed on Oct 12, 2024 is breath-taking. For better visibility, we shortened some answers and indicated that in the text not loosing seriousness :). You: why are CELLETS so beautiful? ChatGPT: CELLETS are beautiful because […]
Scientific literature on MCC pellets (CELLETS®)
Selected Scientific literature on MCC pellets Please, find scientific literature on MCC pellets (CELLETS®), MCC spheres. This list is constantly updated and does not claim to be complete. If you are author, scientist or R&D specialist, please submit your present publication to us for improving the visibility. List – Publications with MCC spheres, 2024 Research […]
A nutritional table for CELLETS®
A nutritional table for CELLETS®, what is it about? CELLETS® are made of 100% microcrystalline cellulose (MCC), developed for state of the art oral dosage forms, such as MUPS, capsules, sachets, stick pack units. Anyway, some pharmaceutical applications move towards food products and vice versa. This field of nutraceutical applications are extending market share and we […]